Germany’s drug pricing system reportedly faces a U.S. trade hearing
POLITICO Europe reports that the consequences could extend beyond pharmaceuticals, with cars potentially affected too.
TLDR
POLITICO Europe reports that Germany’s system for pricing new medicines was scheduled to face a U.S. trade hearing on September 22, 2026. The outlet says the consequences could extend beyond pharmaceuticals to cars.
Combined views
8.5K
2 Sources, first seen 8d ago
6 likes2 comments3 saves5 reposts